Literature DB >> 1402998

Blood glucose, glycosylated haemoglobin, and outcome of ischemic brain infarction.

K Murros1, R Fogelholm, S Kettunen, A L Vuorela, J Valve.   

Abstract

From August 1987 through December 1989 all consecutive conscious patients younger than 70 years with a recent (less than 48 h) brain infarction of the carotid territory were prospectively included in the study. Blood samples for fasting blood glucose and glycosylated haemoglobin (HbA1c) were taken after a median delay of 23 h of the onset of symptoms. The severity of hemiparesis was assessed on admission, at 1 week, 3 weeks, and 3 months. The functional outcome was assessed at 3 months. Computed cerebral tomography was performed on admission, and later on at 3 weeks or 3 months. The brain infarct volume was measured from the CTs. The patients were diagnosed to have prestroke normoglycemia (n = 76) and prestroke hyperglycemia (n = 23) on basis of the HbA1c level. The case fatality rate, severity of hemiparesis, functional outcome, and infarct size did not differ between these 2 groups. On the other hand, fasting blood glucose level of the non-diabetics correlated strongly with the severity of hemiparesis and predicted stroke outcome. A statistically significant correlation was observed between blood glucose values and the volumes of cortical infarcts in non-diabetics. Because prestroke blood glucose level, in contrast to post-stroke blood glucose level, did not have any predictive value concerning stroke outcome it is concluded that high fasting blood glucose values after stroke reflect a stress response to a more severe ischemic brain lesion.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1402998     DOI: 10.1016/0022-510x(92)90112-x

Source DB:  PubMed          Journal:  J Neurol Sci        ISSN: 0022-510X            Impact factor:   3.181


  12 in total

1.  Admission blood glucose and short term survival in primary intracerebral haemorrhage: a population based study.

Authors:  R Fogelholm; K Murros; A Rissanen; S Avikainen
Journal:  J Neurol Neurosurg Psychiatry       Date:  2005-03       Impact factor: 10.154

Review 2.  Critical Care Management of Acute Ischemic Stroke.

Authors:  Matthew B Bevers; W Taylor Kimberly
Journal:  Curr Treat Options Cardiovasc Med       Date:  2017-06

Review 3.  Management of massive cerebral infarct.

Authors:  Galen V Henderson
Journal:  Curr Neurol Neurosci Rep       Date:  2004-11       Impact factor: 5.081

Review 4.  Hyperglycemia in acute ischemic stroke: pathophysiology and clinical management.

Authors:  Nyika D Kruyt; Geert Jan Biessels; J Hans Devries; Yvo B Roos
Journal:  Nat Rev Neurol       Date:  2010-02-16       Impact factor: 42.937

5.  The role of hyperglycemia in acute ischemic stroke.

Authors:  Rachel M Gilmore; Latha G Stead
Journal:  Neurocrit Care       Date:  2006       Impact factor: 3.210

6.  Hyperglycemia is associated with more severe cytotoxic injury after stroke.

Authors:  Matthew B Bevers; Neil H Vaishnav; Ly Pham; Thomas Wk Battey; W Taylor Kimberly
Journal:  J Cereb Blood Flow Metab       Date:  2016-01-01       Impact factor: 6.200

Review 7.  Inflammation in acute ischemic stroke and its relevance to stroke critical care.

Authors:  Hedley C A Emsley; Craig J Smith; Pippa J Tyrrell; Stephen J Hopkins
Journal:  Neurocrit Care       Date:  2008       Impact factor: 3.210

8.  Effects of alteplase in the treatment of acute ischemic stroke.

Authors:  Josef Yayan
Journal:  Int J Gen Med       Date:  2012-09-06

Review 9.  Safety and efficacy of alteplase in the treatment of acute ischemic stroke.

Authors:  Giuseppe Micieli; Simona Marcheselli; Piera Angela Tosi
Journal:  Vasc Health Risk Manag       Date:  2009

10.  The Prediction of Clinical Outcome Using HbA1c in Acute Ischemic Stroke of the Deep Branch of Middle Cerebral Artery.

Authors:  Sung Bong Shin; Tae Uk Kim; Jung Keun Hyun; Jung Yoon Kim
Journal:  Ann Rehabil Med       Date:  2015-12-29
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.